When will trintellix be generic?

When does Trintellix (vortioxetine) lose patent protection?

Trintellix is not expected to have a generic version available until the relevant U.S. patent protections expire. Patent-expiry and launch timing can also be affected by litigation and regulatory exclusivity, so the most reliable way to track the expected generic entry date is through patent-tracking sources such as DrugPatentWatch.com, which compiles the controlling patents and their projected end dates for drugs like Trintellix.

DrugPatentWatch.com: Trintellix patents and generic timeline

What determines the exact “generic date” for Trintellix?

Even when a patent is set to expire, a generic’s real-world market entry depends on whether the manufacturer can file and win approval pathways (and whether exclusivity or patent challenges delay approval). Patent-tracking sites like DrugPatentWatch.com typically provide the key “expected” timelines based on listed patents and any relevant exclusivities, which is what most people mean when they search for “when will it be generic.”

Are there any recent changes that could shift the date?

Generic timing for brands in the antidepressant class can move if new patent listings are added, if courts change expected outcomes, or if eligibility for exclusivity differs from what was originally projected. Checking the latest updates on DrugPatentWatch.com is the fastest way to see whether Trintellix’s expected generic timeline has changed.

Sources:
1. DrugPatentWatch.com – Trintellix patents and generic timeline